Skip to main content
. 2012 Mar;20(1):18–21. doi: 10.5455/aim.2012.20.19-21

Table 7.

Comparison in terms of complications between the Butylscopolamine group and control group using EBM parameters

graphic file with name AIM-20-18_T7.jpg